Clinical Trial

The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study

Study acronym: CROSSROADS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to develop and test the CROSSROADS intervention. CROSSROADS is designed for people who have recently survived an opioid and/or stimulant-related non-fatal overdose and had contact with staff from a Community Paramedic (CP) program. Participants will be randomly placed into one of two groups: 1\) Standard of care from the CP program, or 2) CROSSROADS, which includes CP care plus a Medical-Legal Partnership (MLP). The MLP helps people with legal problems that can affect their health-- like issues with housing or public benefits. Researchers will test if the CROSSROADS intervention reduces drug use and involvement with the criminal legal system. People in the study will be followed for one year and asked to complete surveys at the beginning, and again at 1 month, 6 months, and 12 months.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-14; most recent amendment 2026-04-07.
Trial Details
NCT Number NCT07216963
Lead Sponsor Duke University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opioid Use Disorder, Overdose, Drug, Overdose, Substance Use (Drugs, Alcohol)
Enrollment 400 participants
Start Date 2026-09-01
Primary Completion 2029-09-01 (estimated)
Study Completion 2030-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-13